Literature DB >> 7582449

Cytokine-mediated induction of cyclo-oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide.

P Akarasereenont1, Y S Bakhle, C Thiemermann, J R Vane.   

Abstract

1. The induction of cyclo-oxygenase-2 (COX-2) afforded by bacterial lipopolysaccharide (LPS, endotoxin) in bovine aortic endothelial cells (BAEC) is mediated by tyrosine kinase. LPS also causes the generation of several cytokines including interleukin-1 beta (IL-1 beta), tumour necrosis factor-alpha (TNF-alpha), epidermal growth factor (EGF) and platelet-derived growth factor (PDGF). This study investigates whether endogenous IL-1 beta, TNF-alpha, EGF or PDGF contribute to the induction of COX-2 elicited by LPS in BAEC and if their action is due to activation of tyrosine kinase. Furthermore, we have studied the induction of COX-2 by exogenous cytokines. 2. Accumulation of 6-oxo-prostaglandin (PG) F1 alpha in cultures of BAEC was measured by radioimmunoassay at 24 h after addition of either LPS (1 microgram ml-1) alone or LPS together with a polyclonal antibody to one of the various cytokines. In experiments designed to measure 'COX activity', 6-oxo-PGF1 alpha generated by BAEC activated with recombinant human IL-1 beta, TNF-alpha, EGF or PDGF for 12 h was measured after incubation of washed cells with exogenous arachidonic acid (30 microM for 15 min). Western blot analysis determined the expression of COX-2 protein in BAEC. 3. The accumulation of 6-oxo-PGF1 alpha caused by LPS in BAEC was attenuated by co-incubation with one of the polyclonal antibodies, anti-IL-1 beta, anti-TNF-alpha, anti-EGF, anti-PDGF or with the IL-1 receptor antagonist, in a dose-dependent manner. Exogenous IL-1 beta, TNF-alpha or EGF also caused an increase in COX activity, while PDGF was ineffective. The increase in COX activity elicited by IL-1,beta(10 ng ml-1), TNF-alpha (100 ng ml-1) or EGF (1000 ng ml-1) in BAEC was attenuated by erbstatin (0.005 to 5 microg ml-1), as was the expression of COX-2 protein measured by Western blot analysis.4. PDGF (10 ng ml-1) significantly augmented the rise in COX activity and COX-2 protein caused by shorter incubation of BAEC with LPS (1 microg ml-1 for 3 h). Combination of PDGF (10 ng ml-1) with a low concentration of IL-l beta (1 ng ml-1) for 12 h, also increased 'COX activity', but combination of PDGF and TNF-alpha (10 ng ml-1) did not show any increased activity.5. These results suggest that (i) the induction of COX activity and COX-2 protein elicited by LPS in BAEC is mediated by TNF-alpha with lesser contributions from PDGF, EGF or IL-1 beta; (ii) exogenous IL-1 beta,TNF-alpha or EGF alone induce COX-2 activity and protein in BAEC; (iii) PDGF synergizes with IL-1 beta,but not TNF-alpha, to cause expression of COX-2; and (iv) the induction of COX-2 protein and activity caused by these cytokines involves the activation of tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582449      PMCID: PMC1908422          DOI: 10.1111/j.1476-5381.1995.tb16347.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  53 in total

Review 1.  Therapeutic potential of cytokine manipulation.

Authors:  B Henderson; S Blake
Journal:  Trends Pharmacol Sci       Date:  1992-04       Impact factor: 14.819

Review 2.  Cytokine regulation of endothelial cell function.

Authors:  A Mantovani; F Bussolino; E Dejana
Journal:  FASEB J       Date:  1992-05       Impact factor: 5.191

Review 3.  Signal transduction by receptors with tyrosine kinase activity.

Authors:  A Ullrich; J Schlessinger
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

4.  Kinetic studies of tyrosine kinase inhibition by erbstatin.

Authors:  M Imoto; K Umezawa; K Isshiki; S Kunimoto; T Sawa; T Takeuchi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1987-10       Impact factor: 2.649

5.  Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts.

Authors:  E A Kurt-Jones; W Fiers; J S Pober
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

6.  Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer.

Authors:  J A Maier; P Voulalas; D Roeder; T Maciag
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

7.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.

Authors:  S D Wright; R A Ramos; P S Tobias; R J Ulevitch; J C Mathison
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

8.  Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.

Authors:  W L Xie; J G Chipman; D L Robertson; R L Erikson; D L Simmons
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

9.  The role of cyclooxygenase products in lung injury induced by tumor necrosis factor in sheep.

Authors:  A P Wheeler; W D Hardie; G R Bernard
Journal:  Am Rev Respir Dis       Date:  1992-03

10.  Herbimycin A blocks IL-1-induced NF-kappa B DNA-binding activity in lymphoid cell lines.

Authors:  T Iwasaki; Y Uehara; L Graves; N Rachie; K Bomsztyk
Journal:  FEBS Lett       Date:  1992-02-24       Impact factor: 4.124

View more
  17 in total

1.  Nitric oxide synthase inhibitors attenuate transforming-growth-factor-beta 1-stimulated capillary organization in vitro.

Authors:  A Papapetropoulos; K M Desai; R D Rudic; B Mayer; R Zhang; M P Ruiz-Torres; G García-Cardeña; J A Madri; W C Sessa
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Effect of a nitric oxide releasing derivative of paracetamol in a rat model of endotoxaemia.

Authors:  M Marshall; J Keeble; P K Moore
Journal:  Br J Pharmacol       Date:  2006-08-29       Impact factor: 8.739

3.  New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}.

Authors:  Viktor R Drel; Sergey Lupachyk; Hanna Shevalye; Igor Vareniuk; Weizheng Xu; Jie Zhang; Nicholas A Delamere; Mohammad Shahidullah; Barbara Slusher; Irina G Obrosova
Journal:  Endocrinology       Date:  2010-03-31       Impact factor: 4.736

4.  Knockdown of delta-5-desaturase promotes the anti-cancer activity of dihomo-γ-linolenic acid and enhances the efficacy of chemotherapy in colon cancer cells expressing COX-2.

Authors:  Yi Xu; Xiaoyu Yang; Pinjing Zhao; Zhongyu Yang; Changhui Yan; Bin Guo; Steven Y Qian
Journal:  Free Radic Biol Med       Date:  2016-04-19       Impact factor: 7.376

5.  Anti-inflammatory effects of low molecular weight heparin derivative in a rat model of carrageenan-induced pleurisy.

Authors:  Matteo Ceccarelli; Daniele Bani; Lorenzo Cinci; Silvia Nistri; Caterina Uliva; Elena Ragazzo; Alfredo Vannacci; Marco Manoni; Anna Maria Gori; Rosanna Abbate; Gian Franco Gensini; Emanuela Masini
Journal:  J Cell Mol Med       Date:  2009-08       Impact factor: 5.310

6.  Polydatin-loaded chitosan nanoparticles ameliorates early diabetic nephropathy by attenuating oxidative stress and inflammatory responses in streptozotocin-induced diabetic rat.

Authors:  Abeer M Abd El-Hameed
Journal:  J Diabetes Metab Disord       Date:  2020-11-24

Review 7.  Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes.

Authors:  R De Caterina; M Massaro
Journal:  J Membr Biol       Date:  2005-07       Impact factor: 1.843

8.  Rat pulmonary cyclooxygenase-2 expression in response to endotoxin challenge: differential regulation in the various types of cells in the lung.

Authors:  L Ermert; M Ermert; M Merkle; M Goppelt-Struebe; H R Duncker; F Grimminger; W Seeger
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

9.  Knockdown delta-5-desaturase promotes the formation of a novel free radical byproduct from COX-catalyzed ω-6 peroxidation to induce apoptosis and sensitize pancreatic cancer cells to chemotherapy drugs.

Authors:  Xiaoyu Yang; Yi Xu; Amanda Brooks; Bin Guo; Keith W Miskimins; Steven Y Qian
Journal:  Free Radic Biol Med       Date:  2016-06-28       Impact factor: 7.376

10.  Dexamethasone improves vascular hyporeactivity induced by LPS in vivo by modulating ATP-sensitive potassium channels activity.

Authors:  R d'Emmanuele di Villa Bianca; L Lippolis; G Autore; A Popolo; S Marzocco; L Sorrentino; A Pinto; R Sorrentino
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.